Letters To The Editor
A reader comments on the use of prostate-specific antigen to screen for prostate cancer.
Latest research in 4 areas of men’s health commonly addressed in primary care.
Screening for prostate cancer reduces mortality rates and metastatic disease, and the paradigm continues to evolve.
Options include locally applied estrogens, DHEA, and estrogen receptor agonists/antagonists.
Before menopause, most simple cysts smaller than 5 cm resolve in 2 to 3 menstrual cycles and need no further intervention.
Rule out infection, especially Clostridium difficile, then order colonoscopy or computed tomography.
From the Editor
No one likes adverse effects, but they can teach us important things about human biology.
There is no need to continue Pap testing after hysterectomy for a benign indication.